Challenges to leveraging real-world evidence for FDA approval September 20, 2019Vol.45 No.35By Ash Malik
Conversation with The Cancer LetterFree Michigan’s Philip Stella receives NCORP 2019 Harry Hynes Award September 13, 2019Vol.45 No.34By Paul Goldberg
Trials & Tribulations Barriers to clinical trial enrollmentPart I of a two-part series August 02, 2019Vol.45 No.31By Daniel Wall, Stephanie Engelien and Adedayo A. Onitilo
Conversation with The Cancer Letter IASLC: The Lung Ambition Alliance will amplify initiatives in lung cancer on a global scale July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
Lung Ambition Alliance seeks global partners to double lung cancer survival rates by 2025 July 26, 2019Vol.45 No.30By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Curtis: Women are intrigued by the many questions asked in TMIST July 12, 2019Vol.45 No.28By Paul Goldberg
Trials & Tribulations Lessons from the front lines of value-based care:The OCM's impact on community oncology June 21, 2019Vol.45 No.25By Charles Saunders
Conversation with The Cancer LetterFree FDA’s Project Facilitate uses a call center to streamline access to unapproved cancer therapies June 14, 2019Vol.45 No.24By Paul Goldberg
Conversation with The Cancer LetterFree Project ECHO brings specialized knowledge to rural providers May 31, 2019Vol.45 No.22By Claire Dietz
